Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 2
2021 3
2022 6
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
No correlation of neutralizing antibody titers against the Omicron variant after a booster dose of COVID-19 vaccines with subsequent breakthrough Omicron infections among healthcare workers.
Lee J, Park S, Kim JY, Lim SY, Chang E, Bae S, Jung J, Kim MJ, Chong YP, Lee SO, Choi SH, Kim YS, Lee N, Shum D, Kim S, Jee Y, Kim SH. Lee J, et al. Among authors: park s. J Infect. 2022 Dec;85(6):e177-e180. doi: 10.1016/j.jinf.2022.10.007. Epub 2022 Oct 9. J Infect. 2022. PMID: 36223860 Free PMC article. No abstract available.
Comparison of Waning Neutralizing Antibody Responses Against the Omicron Variant 6 Months After Natural Severe Acute Respiratory Syndrome Coronavirus 2 Infection (With or Without Subsequent Coronavirus Disease 2019 [COVID-19] Vaccination) Versus 2-Dose COVID-19 Vaccination.
Lim SY, Park S, Kim JY, Kim S, Jee Y, Kim SH. Lim SY, et al. Among authors: park s. Clin Infect Dis. 2022 Dec 19;75(12):2243-2246. doi: 10.1093/cid/ciac435. Clin Infect Dis. 2022. PMID: 35686300 Free PMC article.
Garbage in, garbage out: how reliable training data improved a virtual screening approach against SARS-CoV-2 MPro.
Ruatta SM, Prada Gori DN, Fló Díaz M, Lorenzelli F, Perelmuter K, Alberca LN, Bellera CL, Medeiros A, López GV, Ingold M, Porcal W, Dibello E, Ihnatenko I, Kunick C, Incerti M, Luzardo M, Colobbio M, Ramos JC, Manta E, Minini L, Lavaggi ML, Hernández P, Šarlauskas J, Huerta García CS, Castillo R, Hernández-Campos A, Ribaudo G, Zagotto G, Carlucci R, Medrán NS, Labadie GR, Martinez-Amezaga M, Delpiccolo CML, Mata EG, Scarone L, Posada L, Serra G, Calogeropoulou T, Prousis K, Detsi A, Cabrera M, Alvarez G, Aicardo A, Araújo V, Chavarría C, Mašič LP, Gantner ME, Llanos MA, Rodríguez S, Gavernet L, Park S, Heo J, Lee H, Paul Park KH, Bollati-Fogolín M, Pritsch O, Shum D, Talevi A, Comini MA. Ruatta SM, et al. Among authors: park s. Front Pharmacol. 2023 Jun 22;14:1193282. doi: 10.3389/fphar.2023.1193282. eCollection 2023. Front Pharmacol. 2023. PMID: 37426813 Free PMC article.
15 results